LFA
Legend Financial Advisors Portfolio holdings
AUM
$151M
This Quarter Return
-3.72%
1 Year Return
+14.6%
3 Year Return
+62.32%
5 Year Return
+95.34%
10 Year Return
–
AUM
$106M
AUM Growth
+$106M
(+10%)
Cap. Flow
+$13.6M
Cap. Flow
% of AUM
12.79%
Top 10 Holdings %
Top 10 Hldgs %
65.49%
Holding
236
New
205
Increased
5
Reduced
19
Closed
3
Top Buys
| 1 |
Leuthold Core ETF
LCR
|
$7.27M |
| 2 |
Vanguard S&P Small-Cap 600 Value ETF
VIOV
|
$1.44M |
| 3 |
SPDR S&P Biotech ETF
XBI
|
$1.24M |
| 4 |
NMI Holdings
NMIH
|
$513K |
| 5 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
$502K |
Top Sells
| 1 |
Franco-Nevada
FNV
|
$900K |
| 2 |
Corpay
CPAY
|
$510K |
| 3 |
Alpha Metallurgical Resources
AMR
|
$446K |
| 4 |
iShares Gold Trust
IAU
|
$325K |
| 5 |
abrdn Physical Palladium Shares ETF
PALL
|
$294K |
Sector Composition
| 1 | Financials | 2.62% |
| 2 | Technology | 2.23% |
| 3 | Consumer Discretionary | 1.24% |
| 4 | Industrials | 0.91% |
| 5 | Communication Services | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
United Airlines
UAL
$33B
| $2.7K | ﹤0.01% |
+83
| New | +$2.7K |
|
202
Danaher
DHR
$144B
| $2.58K | ﹤0.01% |
+10
| New | +$2.58K |
|
203
Citigroup
C
$172B
| $2.54K | ﹤0.01% |
+61
| New | +$2.54K |
|
204
Bristol-Myers Squibb
BMY
$96.1B
| $2.35K | ﹤0.01% |
+33
| New | +$2.35K |
|
205
Kroger
KR
$45.3B
| $2.19K | ﹤0.01% |
+50
| New | +$2.19K |
|
206
Otis Worldwide
OTIS
$33.5B
| $2.17K | ﹤0.01% |
+34
| New | +$2.17K |
|
207
CVS Health
CVS
$94B
| $2.1K | ﹤0.01% |
+22
| New | +$2.1K |
|
208
Sanofi
SNY
$120B
| $1.71K | ﹤0.01% |
+45
| New | +$1.71K |
|
209
DT Midstream
DTM
$10.6B
| $1.66K | ﹤0.01% |
+32
| New | +$1.66K |
|
210
FS KKR Capital
FSK
$5.05B
| $1.64K | ﹤0.01% |
+97
| New | +$1.64K |
|
211
Electronic Arts
EA
$43.1B
| $1.62K | ﹤0.01% |
+14
| New | +$1.62K |
|
212
Alcon
ALC
$38.8B
| $1.57K | ﹤0.01% |
+27
| New | +$1.57K |
|
213
Haleon
HLN
$43.5B
| $1.49K | ﹤0.01% |
+245
| New | +$1.49K |
|
214
United Rentals
URI
$61.2B
| $1.35K | ﹤0.01% |
+5
| New | +$1.35K |
|
215
Biogen
BIIB
$20.1B
| $1.34K | ﹤0.01% |
+5
| New | +$1.34K |
|
216
Bio-Rad Laboratories Class A
BIO
$7.78B
| $1.25K | ﹤0.01% |
+3
| New | +$1.25K |
|
217
DiaMedica Therapeutics
DMAC
$287M
| $1.24K | ﹤0.01% |
+1,000
| New | +$1.24K |
|
218
Lennar Class A
LEN
$34.3B
| $1.19K | ﹤0.01% |
+16
| New | +$1.19K |
|
219
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$9.58B
| $1.11K | ﹤0.01% |
+12
| New | +$1.11K |
|
220
Skyworks Solutions
SWKS
$10.7B
| $938 | ﹤0.01% |
+11
| New | +$938 |
|
221
United Therapeutics
UTHR
$18.9B
| $838 | ﹤0.01% |
+4
| New | +$838 |
|
222
Snap-on
SNA
$16.8B
| $805 | ﹤0.01% |
+4
| New | +$805 |
|
|
PDM
223
Piedmont Realty Trust, Inc.
PDM
$1.04B
| $803 | ﹤0.01% |
+76
| New | +$803 |
|
224
Viatris
VTRS
$12.2B
| $801 | ﹤0.01% |
+94
| New | +$801 |
|
225
AbbVie
ABBV
$372B
| $671 | ﹤0.01% |
+5
| New | +$671 |
|